Jake Everett Turrentine, MD | |
1899 Tate Blvd Se Ste 2110, Hickory, NC 28602-4200 | |
(828) 328-4449 | |
Not Available |
Full Name | Jake Everett Turrentine |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 13 Years |
Location | 1899 Tate Blvd Se Ste 2110, Hickory, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386934933 | NPI | - | NPPES |
072838 | Other | GA | GA LICENSES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Skin Surgery Center Pa | 3173599479 | 54 |
News Archive
The use of heart bracelets connected via ICT to a system of tracking and monitoring could prevent cases of sudden death in sports activities.
A new guide developed by The National Business Group on Health and the National Comprehensive Cancer Network offers employers an online and interactive toolkit to help address the growing impact of cancer in the workplace.
A researcher at the University of York, studying male attitudes towards self-managing long-term healthcare issues, has discovered that self-management support is better received by men if it does not threaten aspects of masculine identity.
Results of a study, involving 98,454 patients demonstrated that at 30 days following their first heart attack, RA patients were approximately 20% less likely to be prescribed standard MI treatments, such as statins and betablockers, compared to healthy patients.
Dyax Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted approval for KALBITOR® (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older.
› Verified 1 days ago
Entity Name | Skin Surgery Center Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649237082 PECOS PAC ID: 3173599479 Enrollment ID: O20040908000943 |
News Archive
The use of heart bracelets connected via ICT to a system of tracking and monitoring could prevent cases of sudden death in sports activities.
A new guide developed by The National Business Group on Health and the National Comprehensive Cancer Network offers employers an online and interactive toolkit to help address the growing impact of cancer in the workplace.
A researcher at the University of York, studying male attitudes towards self-managing long-term healthcare issues, has discovered that self-management support is better received by men if it does not threaten aspects of masculine identity.
Results of a study, involving 98,454 patients demonstrated that at 30 days following their first heart attack, RA patients were approximately 20% less likely to be prescribed standard MI treatments, such as statins and betablockers, compared to healthy patients.
Dyax Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted approval for KALBITOR® (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Jake Everett Turrentine, MD 1899 Tate Blvd Se Ste 2110, Hickory, NC 28602-4200 Ph: (828) 328-4449 | Jake Everett Turrentine, MD 1899 Tate Blvd Se Ste 2110, Hickory, NC 28602-4200 Ph: (828) 328-4449 |
News Archive
The use of heart bracelets connected via ICT to a system of tracking and monitoring could prevent cases of sudden death in sports activities.
A new guide developed by The National Business Group on Health and the National Comprehensive Cancer Network offers employers an online and interactive toolkit to help address the growing impact of cancer in the workplace.
A researcher at the University of York, studying male attitudes towards self-managing long-term healthcare issues, has discovered that self-management support is better received by men if it does not threaten aspects of masculine identity.
Results of a study, involving 98,454 patients demonstrated that at 30 days following their first heart attack, RA patients were approximately 20% less likely to be prescribed standard MI treatments, such as statins and betablockers, compared to healthy patients.
Dyax Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted approval for KALBITOR® (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older.
› Verified 1 days ago
Dr. Jerry L Pruitt, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 245 11th Ave Ne, Hickory, NC 28601 Phone: 828-328-3500 Fax: 828-328-8777 | |
Dr. Bethany Bergamo, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1927 3rd Avenue Ln Se, Hickory, NC 28602 Phone: 828-328-3500 Fax: 828-328-8777 | |
Dr. George Dimitri Magel, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 315 19th St Se, Hickory, NC 28602 Phone: 828-325-9849 Fax: 828-325-9879 | |
Charles S Johnson, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 315 19th St Se, Hickory, NC 28602 Phone: 828-325-9849 Fax: 828-325-9879 | |
Dr. Karen Trygg Wold, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1985 Tate Blvd Se, Hickory, NC 28602 Phone: 828-328-4449 Fax: 828-328-4809 | |
Dori L Hunt, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1927 3rd Avenue Ln Se, Hickory, NC 28602 Phone: 828-328-3500 Fax: 828-328-8777 |